ANNUALREPORT
LIFEHOUSEGYNAECOLOGICALONCOLOGYGROUP
2016
Preparedby
ProfessorJonathanCarter
MBBS,DipRACOG,FACS,FRANZCOG,MS,MD,CGOProfessorGynaecologicalOncology,TheUniversityofSydney
Head,LifehouseGynaecologicalOncologyGroup
ProvidingExcellencein
Teaching,Research,Education,PatientCare,Administration
2
3
TableofContentsIntroduction......................................................................................................................4
Highlights..........................................................................................................................5
SummaryStatistics............................................................................................................6OverallActivity...........................................................................................................................6NewCancers..............................................................................................................................6InPatient...................................................................................................................................6OutPatient................................................................................................................................6MajorSurgery............................................................................................................................6MinorSurgery............................................................................................................................7LOS.............................................................................................................................................7KPI’s...........................................................................................................................................7AE’sGrade3&4.........................................................................................................................7MeetingAttendance..................................................................................................................7
Publications.......................................................................................................................8
InternationalPresentations.............................................................................................10
BookChapters.................................................................................................................10
NationalPresentations....................................................................................................10
StatePresentations.........................................................................................................12
LocalandRegionalPresentations....................................................................................12
Abstracts.........................................................................................................................14
AdministrativeResponsibilities&Committees................................................................14
PhD&ResearchSupervision............................................................................................15
Grant,Trial&ManuscriptReviews2016..........................................................................16
RANZCOGActivities.........................................................................................................18
EthicsSubmissions..........................................................................................................18
GrantsSubmissions.........................................................................................................19
MembershipsinProfessionalOrganizations....................................................................19
EditorialCommittee........................................................................................................19
CourseOrganizationorInstruction..................................................................................19
InvitedLectureship,Guest,ProgramChair,GrandRoundsPresentations.........................20
Teaching,MedicalStudent&UniversityActivities...........................................................20
Courses&ConferencesAttended....................................................................................21
Fundraising,Media..........................................................................................................22
Research.........................................................................................................................23
4
IntroductionIt is an honor and privilege, as Head of the LifehouseGynaecologic Oncology Group, to present the 2016AnnualReportfortheLifehouseGynaecologicOncologyGroup.This year concludes our 3rd yearwithin Lifehouse.MyDepartmentcontinuestodevelopandexpand.Ourseniormedical staff comprise myself, A/Prof Selvan Pather,A/ProfSamSaidiandA/ProfTrevorTejada-Berges.OurseniornursesareShannonPhilp,ourNursePractitionerand Belinda Zielony our Clinical Nurse Consultant. Dr.Luciano Rangel from Brazil and Dr. Pearl Tong from
SingaporeareourFellowsandDr.KingManWanourLifehouseGynaecologicOncologyRegistrar. Stephen Cotterell remains our data manager and programmer for ourDatabaseandPatientManagementSystem.OureverfaithfulandreliableChristineYoungisourPatientNavigator.
5
Highlights1. ProfCarterwasinvitedtowriteanEditorialforMedicalJournalofAustraliaon
theRenewaloftheNationalCervicalCancerScreeningProgram,whichsubsequentlyledtomediainterviewsonChannel9andABCRadioNational(http://www.abc.net.au/radionational/programs/healthreport/cervical-cancer-screening/7938108#transcript)
2. A/ProfMarceloNascimentowasappointedtotheUnitandtothenewlyformedAdvancedGISurgicalProgramatRPAH.
3. A/ProfPatherwasamemberoftheRenewalPanelfortheNationalCervicalScreeningProgramme.
4. A/ProfSaidipassedhiswrittenexaminationoftheCGOexaminationon19thJuly2016andwassubsequentlyawardedfullCGOcertificationon29thNovember2016.
5. A/ProfSaidicommencedRapidAccessHysteroscopyservice.6. A/ProfTejada-BergeswasappointedtotheEducationalCommitteeofthe
InternationalGynecologicCancerSociety(IGCS).7. A/ProfTejada-Bergesperformedthe100throboticsurgeryatChrisO’Brien
Lifehouseon2ndNovember2016.8. A/ProfTejada-BergespassedtheoralcomponentofCGOExaminationon20th
November2016.9. BelindaZielonywasappointedtoCancerNursesSocietyofAustralia(CNSA)
GynaecologicalSpecialistPracticeNetworkCommittee.
6
SummaryStatisticsOverallActivityYear Inpatients Outpatients NewCancers2014 669 6162 2292015 749 6181 2242016 825 7214 252NewCancers
Carter Pather Saidi Tejada-Berges
Other Total
2014 50 70 45 61 3 2292015 48 64 61 48 3 2242016 60 68 56 60 8 252NewCancers(Breakdownbytumoursite)Year New
CancersCervix Corpus Uterine
SarcomaOvary SexCord
StromalGermCell
Vulva Vagina
2014 229 40(17%) 66(29%) 11(4.8%) 53(23%) 3(1.3%) 2(0.87%) 14(6.1%) 0(0%)2015 224 30(13%) 63(28%) 9(4%) 62(28%) 2(0.89%) 4(1.8%) 10(4.5%) 2(0.89%)2016 252 31(12%) 93(37%) 7(2.8%) 63(25%) 4(1.6%) 3(1.2%) 15(6%) 2(0.79%)
InPatient
Carter Pather Saidi Tejada-Berges
Other Total
2014 205 202 109 153 0 6692015 177 226 149 197 0 7492016 181 233 192 206 13 825IncludesConsultsOutPatient
Carter Pather Saidi Tejada-Berges
Other Total
2014 1493 1867 1203 1211 388 61622015 1414 1593 1444 1465 265 61812016 1362 1751 1846 1613 642 7214MajorSurgery
Carter Pather Saidi Tejada-Berges
Other Total
2014 60 114 63 114 0 3512015 47 95 81 102 1 3262016 58 100 81 89 9 337
7
MinorSurgery
Carter Pather Saidi Tejada-Berges
Other Total
2014 118 67 29 27 0 2412015 110 95 54 65 0 3242016 106 125 94 92 7 424LOS Carter Pather Saidi Tejada-
BergesOther Total
2014 2.84 2.74 2.12 3.66 - 2.842015 2.85 2.78 2.55 2.89 2.772016 3.22 2.97 2.2 2.84 2.81KPI’s Carter Pather Saidi Tejada-
BergesOther Total
2014 21 21 18 26 0 862015 13 15 15 19 0 622016 18 26 19 19 5 87AE’sGrade3&4
Carter Pather Saidi Tejada-Berges
Other Total
2014 4 5 1 10 0 202015 4 3 4 2 0 132016 8 15 5 6 0 34MeetingAttendance
Carter Pather Saidi Tejada-Berges
Other Total
2014MDTM&M
378
346
4110
4111
--
2015MDTM&M
418
367
409
379
--
2016MDTM&M
359
357
4010
3911
--
8
Publications
Carter1. BlainG,RichardsA,PatherS,CarterJ,SaidiS.Aretrospectiveobservational
studyfortheoutcomesofwomenpresentingtoacolposcopyclinicwithahighgradePapsmear-implicationsfora“seeandtreat”approachtomanagement.AustNZJObstetGynaecol2016;56:207-211.
2. WanKM,CarterJ,PhilpS.PredictorsofearlydischargeafteropengynaecologicalsurgeryinthesettingofanEnhancedRecoveryAfterSurgeryprotocol.JObstetGynecolResearch2016;42(10):1369-1374.
3. MittalP,Klingler-HoffmanM,ArentzG,WinderbaumL,LokmanNA,ZhangC,AndersonL,ScurryJ,LeungY,StewartC,CarterJ,KaurGOehlerM,Hoffmann.Lymphnodemetastasisofprimaryendometrialcancers:associatedproteinsrevealedbyMALDIimaging.Proteomics2016;16:1793-1801.
4. CarterJ,WanKM,PhilpS.Optimisingrecoveryaftersurgery.Predictorsofearlydischargeandhospitalreadmission.ANZJOG2016;56:489-495.
5. OvarianCancerAssociationConsortium,BreastCancerAssociationConsortium,andConsortiumofModifiersofBRCA1andBRCA2,HollestelleA,vanderBaanFH,BerchuckA,JohnattyS,AbenKK,AgnarssonBA,AittomäkiK,AlducciE,AndrulisIL,Anton-CulverH,AntonenkovaNN,AntoniouAC,ApicellaC,ArndtV,ArnoldN,ArunBK,ArverB,AshworthA,AustralianOvarianCancerStudyGroup,BagliettoL,BalleineR,BanderaEV,BarrowdaleD,BeanYT,BeckmannL,BeckmannMW,BenitezJ,BergerA,BergerR,BeuselinckB,BisognaM,BjorgeL,BlomqvistC,BogdanovaNV,BojesenA,BojesenSE,BollaMK,BonanniB,BrandJS,BrauchH,BreastCancerFamilyRegister,BrennerH,BrintonL,Brooks-WilsonA,BruinsmaF,BrunetJ,BrüningT,BudzilowskaA,BunkerCH,VALIDHTML,BurwinkelB,ButzowR,BuysSS,CaligoMA,CampbellI,CarterJetal.NoclinicalutilityofKRASvariantrs61764370forovarianorbreastcancer.GynecologicOncology2016;141,(2):386-401.
6. CarterJ.TherenewaloftheNationalCervicalScreeningProgram.Editorial.MJA2016;205(8):357-358.
7. CarterJ.HammondI,SmithM.Letter.MJA2016(InPress).8. RebbeckR,FriebelT,MitraN,FeiF,ChenS,AndrulisI,ApostolouP,ArnoldN,
ArunB,BarrowdaleD,BenitezJ,BergerR,BerthetP,BorgA,BuysS,CaldesT,CarterJetal.InheritanceofDeleteriousMutationsatBothBRCA1andBRCA2inanInternationalSampleof32,295Women.BreastCancerResearch2016(InPress).
9. MittalP,Klingler-HoffmannM,ArentzG,WinderbaumL,KaurG,AndersonL,ScurryJ.LeungY,StewartC,CarterJ,HoffmanP,OehlerM.AnnexinA2andalphaactinin4expressioncorrelateswithmetastaticpotentialofprimaryendometrialcancer.BiochimicaetBiophysicaActa2016(InPress).
10. FarrellR,DixonS,CarterJ,WebbPM.Lymphadenectomyinearly-stageintermediate/high-riskendometrioidendometrialcancer:clinicalcharacteristicsandoutcomesinanAustraliancohort.IntJGynCancer2016(InPress)
11. MortonR,AndersonL,CarterJ,PatherS,SaidiSA.IntraoperativeFrozenSectionofOvarianTumors:A6-YearReviewofPerformanceandPotentialPitfallsinanAustralianTertiaryReferralCenter.IntJGynecolCancer.2016Dec3.[Epubaheadofprint]
9
12. HayesS,JandaM,LeighC,WardLC,Reul-HircheH,CarterJ,QuinnM,SteeleML,CornishB,ObermairA.Lymphedemafollowinggynecologicalcancer:Resultsfromaprospective,longitudinalcohortstudy.TheLancetOncology.2016(Submitted).
Pather1. BlainG,RichardsA,PatherS,CarterJ,SaidiS.Aretrospectiveobservational
studyfortheoutcomesofwomenpresentingtoacolposcopyclinicwithahigh-gradePapsmear-Implicationsfora'seeandtreat'approachtomanagement.AustNZJObstetGynaecol.2016Apr;56(2):207-11
2. DavisG,AndersonL,PatherS.ExtramammaryPaget’sdiseasemimickinglocalizedmalignancyoncervicalcytology.DiagnCytopathol.2016Nov;44(11):931-934.
3. MortonR,AndersonL,CarterJ,PatherS,SaidiSA.IntraoperativeFrozenSectionofOvarianTumors:A6-YearReviewofPerformanceandPotentialPitfallsinanAustralianTertiaryReferralCenter.IntJGynecolCancer.2016Dec3.[Epubaheadofprint]
Saidi1. SaidiS.ConsidertheTwist.AustralianDoctor12thFeb2016p16.2. MortonR,AndersonL,CarterJ,PatherS,SaidiSA.IntraoperativeFrozenSection
ofOvarianTumors:A6-YearReviewofPerformanceandPotentialPitfallsinanAustralianTertiaryReferralCenter.IntJGynecolCancer.2016Dec3.[Epubaheadofprint]
Tejada-Berges1. Tejada-BergesT.BreastCancer:GeneticsandRiskAssessment.ClinObstet
Gynecol.2016Dec;59(4):673-687.
Philp1. PhilpS,Mellon,A,BarnettC,D’AbrewN,WhiteK.Theroadlesstravelled:
AustralianWomen’sexperienceswithvulvalcancer.EuropeanJournalofCancerCare2016;doi:10.1111/ecc.12465
2. CarterJ,PhilpS,WanK.Optimisingrecoveryaftersurgery:Predictorsofearlydischargeandhospitalreadmission.AustralianandNewZealandJournalofObstetricsandGynaecology2016;56(5):489-495.
3. WanKM,CarterJ,PhilpS.PredictorsofearlydischargeafteropengynaecologicalSurgeryinthesettingofanenhancedrecoveryaftersurgeryprotocol.JournalofObstetricsandGynaecologyResearch2016;42(10):1369-1374.doi:10.1111/jog.1304
4. PhilpS,BarnettC,D’AbrewN,WhiteK.Nurseconfidenceingynaecologicaloncologypracticeandtheevaluationofaprofessionaldevelopmentmodule.SubmittedtoContemporaryNurse
Other1. WanKM,CarterJ,PhilipS.Predictorsofearlydischargeafteropen
gynaecologicalsurgeryinthesettingofanEnhancedRecoveryAfterSurgeryprotocol.JObstetGynecolResearch2016;42(10):1369-1374.
2. CarterJ,WanKM,PhilpS.Optimisingrecoveryaftersurgery.Predictorsofearlydischargeandhospitalreadmission.ANZJOG2016;56:489-495
10
InternationalPresentations
Philp1. LopezAL,JuraskovaI,CostaD,HobbsK,RobertsonR,PhilpS,PhillipsE,Butow
P.Psychosocialneedsofwomenwithgynaecologicalcancer:Prevalenceandcorrelationidentifiedbyanewlydevelopedgynaecologicalcancerneedsquestionnaire(GCNQ).eposterpresentationattheMultinationalAssociationofSupportiveCareinCancer(MASCC)InternationalConference,Adelaide,22-24June,2016
BookChapters
Pather1. AndersonL,PatherS,WrightG,HammondI,SavilleM.NationalCervical
ScreeningProgramme.Clinicalquestion:Diagnosisofhigh-gradesquamousabnormalities.NHMRCinpress
2. AndersonL,PatherS,WrightG,HammondI,SavilleM.NationalCervicalScreeningProgrammeGuidelines:Cervicalcancer/Screening/DiscussionHSIL—NHMRCinpress
3. AndersonL,PatherS,WrightG,HammondI,SavilleM.NationalCervicalScreeningProgrammeClinicalquestion:Follow-upofhighgradesquamouslesionspost-treatment:cytologyandHPVtestingat12vsat12and24mo(bodyofevidence·screenliteratureupdates)—NHMRCinpress
4. BrandA,HammondI,PatherS,RoeskeL,WredeD,NationalCervicalScreeningProgramme.Screeninginimmune-deficientwomen.NHMRCinpress.
5. AndersonL,GarretA,HammondI,PatherS,NationalCervicalScreeningProgramme.Clinicalquestion:Managementoflow-gradecervicalsquamousabnormalitiesinHPV-positivewomen.NHMRCinpress
6. AndersonL,PatherS,WrightG,HammondI,SavilleM.NationalCervicalScreeningProgrammeClinicalquestion:TestofCureaftertreatmentforHSIL(CIN23)(bodyofevidence·screenliteratureupdates).NHMRCinPress
7. AndersonL,PatherS,WrightG,HammondI,SavilleM.NationalCervicalScreeningProgrammeClinicalquestion:Treatmentofhigh-gradesquamousabnormalities(bodyofevidence·screenliteratureupdates)—NHMRCinpress
8. AndersonL,HammondI,PatherS,WredeD,WrightH,Guidelines:Cervicalcancer/Screening/Managementofglandularabnormalities—NHMRCinPress.
9. AndersonL,PatherS,WrightG,HammondI,SavilleM.NationalCervicalScreeningProgrammeGuidelines:Cervicalcancer/Screening/Managementhistologicallyconfirmedhigh-gradesquamousabnormalities.NHMRCinpress
NationalPresentations
Carter1. TongP,PatherS,LeeP,RomeP,CarterJ.Clearcellcarcinomaarisingfrom
previousCaesareansectionscar.PosterPresentationatthe2016ASGOAnnualScientificMeeting.Tasmania,19-21stMay2016
2. WanKM,CarterJ,PhilpS,"Predictorsofearlydischargeafteropengynecologicalsurgeryinthesettingofanenhancedrecoveryaftersurgeryprotocol."PosterpresentationASGOASMTasmania,19-21stMay2016
11
Pather1. TongP,PatherS,LeeP,RomeP,CarterJ.Clearcellcarcinomaarisingfrom
previousCaesareansectionscar.PosterPresentationatthe2016ASGOAnnualScientificMeeting.Tasmania,19-21stMay2016
2. PatherS.Principlesofelectrosurgeryandlaser.ASCCPtreatmentcourseingynaecologicdysplasia.Lifehouse,SydneyAustralia.19thDecember2016.
3. PatherS.Techniqueoflaserandsafetyissues.ASCCPtreatmentcourseingynaecologicdysplasia.Lifehouse,SydneyAustralia.19thDecember2016.
Tejada-Berges1. Tejada-BergesT.CervicalDiseaseManagement:ExcisionalTechniques.ASCCP
CourseandUpdate.GoldCoast,QLD.2ndApril20162. Tejada-BergesT.ColposcopyintheYoungandOld.ASCCPCourseandUpdate.
GoldCoast,QLD.3rdApril2016.3. Tejada-BergesT.Vulvarintra-epithelialneoplasia(VIN)andanalintra-
epithelialneoplasia(AIN).ASCCPCourseandUpdate.GoldCoast,QLD.3rdApril2016.
4. Tejada-BergesT.ColposcopyintheYoungandOld.ASCCPCourseandUpdate.Darwin,NT.18thSeptember2016.
5. Tejada-BergesT.Vulvarintra-epithelialneoplasia(VIN)andanalintra-epithelialneoplasia(AIN).ASCCPCourseandUpdate.Darwin,NT.18thSeptember2016.
Philp1. LopezAL,JuraskovaI,CostaD,HobbsK,RoberstsonR,PhilpS,PhillipsE,Butow
P.Psychosocialneedsofwomenwithgynaecologicalcancer:Prevalenceandcorrelationidentifiedbyanewlydevelopedgynaecologicalcancerneedsquestionnaire(GCNQ).Oralpresentation,AustralianNewZealandGynaecologicalOncologyGroup(ANZGOG),ASM,13-16April,2016
2. WanKM,CarterJ,PhilpS,"Predictorsofearlydischargeafteropengynecologicalsurgeryinthesettingofanenhancedrecoveryaftersurgeryprotocol."PosterpresentationASGOASMTasmania,19-21stMay2016
Other1. TongP,PatherS,LeeP,RomeP,CarterJ.Clearcellcarcinomaarisingfrom
previousCaesareansectionscar.PosterPresentationatthe2016ASGOAnnualScientificMeeting.Tasmania,19-21stMay2016
2. WanKM,CarterJ,PhilpS,"Predictorsofearlydischargeafteropengynecologicalsurgeryinthesettingofanenhancedrecoveryaftersurgeryprotocol."PosterpresentationASGOASMTasmania,19-21stMay2016
12
StatePresentations
Pather1. PatherS,GirgisA,ButowP.SelfCareforprofessionals.PanelDiscussion.
InnovationsinCancerTreatmentandCareConference.CancerCouncilofNSW.16September2016.TechnologyPark,Redfern.Sydney.
Other1. El-AchiV,MarshallD,WanKM,ChuaS,McGeeT,“Readmissionsforsurgicalsite
infectionsfollowingcaesareansection”2016RANZCOGNSW/QLDRegionalScientificMeeting,11-12thJune2016
LocalandRegionalPresentations
Carter1. RangelL,Tejada-BergesT,PatherS,CarterJ,SaidiS.Outcomesfollowing
treatmentforCIN2/3inanAustralianpopulation.Posterpresentation.ChrisO’BrienLifehouseResearchSymposium.14thOctober2016.
2. TongP,PatherS,LeeP,RomeP,CarterJ.ClearcellcarcinomaarisingfromapreviousCaesareansectionscar.Posterpresentation.ChrisO’BrienLifehouseResearchSymposium.14thOctober2016.
3. WanKM,Tejada-BergesT,PatherS,CarterJ,SaidiS.TheuseofaModifiedCapriniScoreingynaecologicaloncologypatients.Oralpresentation.ChrisO’BrienLifehouseResearchSymposium.14thOctober2016.
Pather1. RangelL,Tejada-BergesT,PatherS,CarterJ,SaidiS.Outcomesfollowing
treatmentforCIN2/3inanAustralianpopulation.Posterpresentation.ChrisO’BrienLifehouseResearchSymposium.14thOctober2016.
2. TongP,PatherS,LeeP,RomeP,CarterJ.ClearcellcarcinomaarisingfromapreviousCaesareansectionscar.Posterpresentation.ChrisO’BrienLifehouseResearchSymposium.14thOctober2016.
3. WanKM,Tejada-BergesT,PatherS,CarterJ,SaidiS.TheuseofaModifiedCapriniScoreingynaecologicaloncologypatients.Oralpresentation.ChrisO’BrienLifehouseResearchSymposium.14thOctober2016.
Saidi1. SaidiS.RapidAccessHysteroscopy–a‘OneStop’Shop.LifehouseGP
educationalevent.1stSept20162. SaidiS.ASCCPtrainingcourse.TechniqueofLEEPandsafetyaspects.17th
November20163. SaidiS.ImaginginOvarianCancer.AlfredImaging,CampsieNSW.8thApril2016
Tejada-Berges1. Tejada-BergesT.SexualhealthinWomenFollowingCancerTreatment.GP
Seminar.ChrisO’BrienLifehouse.16thMarch2016.2. Tejada-BergesT.CervicalCancerDiagnosis,StagingandSurgicalManagement.
ACIGynaecologicalOncologyNurses&AlliedHealthGroup(GONG)SeminarDay,RPAH.3rdJune2016.
13
3. Tejada-BergesT.HeyDoc,Ihearthere’sanewscreeningtestforovariancancer?GPSeminar.ChrisO’BrienLifehouse.1stSeptember2016.
4. Tejada-BergesT.RANZCOGReviewLecture:GynaecologicOncologyReview.ConcordHospital.13thMarch2016.
5. Tejada-BergesT.RANZCOGReviewLecture:GynaecologicOncologyReview.ConcordHospital.14thAugust2016.
Other1. RangelL,Tejada-BergesT,PatherS,CarterJ,SaidiS.Outcomesfollowing
treatmentforCIN2/3inanAustralianpopulation.Posterpresentation.ChrisO’BrienLifehouseResearchSymposium.14thOctober2016.
2. TongP,PatherS,LeeP,RomeP,CarterJ.ClearcellcarcinomaarisingfromapreviousCaesareansectionscar.Posterpresentation.ChrisO’BrienLifehouseResearchSymposium.14thOctober2016.
14
3. WanKM,Tejada-BergesT,PatherS,CarterJ,SaidiS.TheuseofaModifiedCapriniScoreingynaecologicaloncologypatients.Oralpresentation.ChrisO’BrienLifehouseResearchSymposium.14thOctober2016.
Abstracts
Carter1. CarterJ.AdvancesinGynaecologicalCancerScreening.HPVandVaccination.
ChrisO’BrienLifehouse.1stSeptember20162. RangelL,Tejada-BergesT,PatherS,CarterJ,SaidiS.Outcomesfollowing
treatmentforCIN2/3inanAustralianpopulation.Posterpresentation.ChrisO’BrienLifehouseResearchSymposium.14thOctober2016.
3. TongP,PatherS,LeeP,RomeP,CarterJ.ClearcellcarcinomaarisingfromapreviousCaesareansectionscar.Posterpresentation.ChrisO’BrienLifehouseResearchSymposium.14thOctober2016.
4. WanKM,Tejada-BergesT,PatherS,CarterJ,SaidiS.TheuseofaModifiedCapriniScoreingynaecologicaloncologypatients.Oralpresentation.ChrisO’BrienLifehouseResearchSymposium.14thOctober2016.
Pather1. TongP,PatherS,CarterJ.Malignanttransformationinendometriosisinthe
anteriorabdominalwall.ASGOPeppersCradleMountainLodge,Tasmania18-21May2016.
2. RangelL,TejadaBergesT,PatherS,CarterJ,SaidiS.OutcomesfollowingtreatmentofCIN2/3inanAustralianpopulation.LifehouseresearchsymposiumLifehouse,Sydney,Australia.14thOctober2016,
Other1. RangelL,Tejada-BergesT,PatherS,CarterJ,SaidiS.Outcomesfollowing
treatmentforCIN2/3inanAustralianpopulation.Posterpresentation.ChrisO’BrienLifehouseResearchSymposium.14thOctober2016.
2. TongP,PatherS,LeeP,RomeP,CarterJ.ClearcellcarcinomaarisingfromapreviousCaesareansectionscar.Posterpresentation.ChrisO’BrienLifehouseResearchSymposium.14thOctober2016.
3. WanKM,Tejada-BergesT,PatherS,CarterJ,SaidiS.TheuseofaModifiedCapriniScoreingynaecologicaloncologypatients.Oralpresentation.ChrisO’BrienLifehouseResearchSymposium.14thOctober2016.
AdministrativeResponsibilities&Committees
Carter1. CarterJ.CommitteeMemberLifehouseClinicalLeadershipCommittee.2. CarterJ.ChairmanLifehouseMDACCommittee.3. CarterJ.ChairmanLifehouseTheatreAdvisoryCommittee.4. CarterJ.CommitteeMemberScientificAdvisoryPanel.TheAustralian
GynaecologicalCancerFoundation.5. CarterJ.CommitteeMemberScientificAdvisoryPanel.CompassTrial.6. CarterJ.CommitteeMemberSLHDAdvancedGISurgicalProgramSteering
Committee.
15
7. CarterJ.CommitteeMemberUro-OncologyInterviews.5thJanuary20168. CarterJ.CommitteeMemberHeadDepartmentBreastService1st&3rdMarch
2016
Pather1. PatherS.MemberoftheguidelinescommitteefortheNationalCervical
ScreeningProgramme.2. PatherS.MemberoftheMorbidityandMortalityCommitteeLifehouse.3. PatherS.CGOExaminationCommittee,RANZCOG4. PatherS.SteeringCommitteeOptimisingcervicalcancerpreventionamongst
AboriginalwomeninruralandremoteNewSouthWales5. PatherS.GynaecologicalOncologyModelScopeofClinicalPracticeCommittee,
20166. PatherS.ExecutiveMemberofASCCP
Tejada-Berges1. Tejada-BergesT.Co-optedMemberofAustralianSocietyofColposcopyand
CervicalPathology(ASCCP)CommitteeofManagement.Feb2016.2. Tejada-BergesT.EducationalCommitteeofInternationalGynecologicCancer
Society(IGCS).August2016.3. Tejada-BergesT.LifehouseRoboticSteeringCommittee.4. Tejada-BergesT.LifehouseRepresentativetoSLHDSurgicalRoboticsProgram
SteeringCommittee
Philp1. PhilpS.NSWACIGynaecologicalOncologyNursesGroup(GONG)Executive
Committee2. PhilpS.CNSA,GynaecologicalOncologySpecialistPracticeNetwork(GYNSPN)3. PhilpS.CNSANPSpecialistPracticeNetwork(NPSPN)4. PhilpS.CNSA,GYNSPN,2016Pre-Congressworkshopcommittee5. PhilpS.AdvisoryTeam,PreceptorshipofvisitingHongKongCancerNurses,
Lifehouse,October-November2016
Zielony1. ZielonyB.NSWACIGynaecologicalOncologyNurses&AlliedHealthGroup
(GONG)ExecutiveCommittee2. ZielonyB.CancerNursesSocietyofAustralia(CNSA)GynaecologicalSpecialist
PracticeNetworkCommitteeMember
PhD&ResearchSupervision
Carter1. CarterJ.Theroleofnaturaltreatmentintheregressionofearlycervical
dysplasiacausedbyhighriskHPV.Asystematicreviewoftheevidencefortheeffectivenessofnaturaltherapies(Carotenoids/micronutrients)intheregressionofcervicaldysplasiaandhighriskHPV.PhDSupervisionDr.PauletteMaroun.UniversityofTechnologySydney.2016
Pather1. PatherS.DrUHerbst.CIN2inanHPVnegativepopulation
16
2. PatherS.PearlTong.Pyometria,Acasereport3. PatherS.PearlTong.ManagementofStage2endometrialcancer4. PatherS.ReviewoftheThesisfulfillingtherequirementsfortheCGO–
Radiotherapyforisolatednodalrecurrenceingynaecologiccancer.11/2016
Saidi1. SaidiS.EskaroosM.AcceptabilityofoutpatientvsinpatientLEEPbiopsy.2. SaidiS.FeddersenJ.BleedingpatternsfollowingLEEPbiopsy,riskfactorsand
outcomes.3. SaidiS.GreyM.eQOLmeasurementtoolingynaecologicalcancerfollow-up4. SaidiS.LeighNicholson.TheRoleofalpha-parvininendometrialcancer.5. SaidiS.LucianoRangel.OutcomesfollowingtreatmentofCIN2/3
Philp1. PhilpS.AssociateSupervisorforDoctorofPhilosophyCandidate:Testingthe
feasibilityofabriefnurse-ledlifestyleinterventionforwomenwithtype1endometrialcancer,SchoolofNursing,TheUniversityofSydney-Thesissubmitted
Grant,Trial&ManuscriptReviews2016
Carter1. CarterJ.Manuscriptreview.Prognosticsignificanceoffluorodeoxyglucose
positronemissiontomographymaximumstandardizeduptakevalueinstageIovarianclearcellcarcinoma:aretrospectiveobservationalstudy.HaruhisaKonishi,KazuhiroTakehara,ShinichiOkame,MasaakiKomatsu,YukoShiroyama,TakashiYokoyama,YoshifumiSugawara.OpenJournalofObstetricsandGynecology30thJanuary2016
2. CarterJ.Manuscriptreview.ManuscriptNumberIGC-D-16-00020.Improveddetectionrateofovariancancerusingatwo-steptriagemodeloftheRiskofMalignancyIndex(RMI)andexpertsonographyinanoutpatientscreeningsetting.6thFebruary2016
3. CarterJ.Manuscriptreview.ManuscriptNumberIJG-D-16-00121.Theprognosisofhighriskearlystagecervicalcancerpatientswhodidnotreceivepostoperativeconcurrentchemoradiotherapy.9thFebruary2016
4. CarterJ.Manuscriptreview.ManuscriptNumbermja15.01404.Qualityofsalpingoophorectomyforovariancancerprevention:stillroomforimprovement.16thFebruary2016
5. CarterJ.Manuscriptreview.ManuscriptNumberW16-0301.Menstrualpatternafterabdominalradicaltrachelectomy.AmJObstetGynecol.WuXetal.28thFebruary2016
6. CarterJ.Manuscriptreview.ManuscriptNumberANZJOG-2016-0036.Theroleofsurgicalstaginginthetreatmentofapparentearly-stagemalignantovariangermcelltumours.AustNZJObstetGynaecol.13thMarch2016
7. CarterJ.ManuscriptReview.ANZJOG-2016-0054.Outcomesofgeneticparticipationingynaecological-oncologymultidisciplinarymeetings:changingpatternsofreferralandoutcomes.27thMarch2016
17
8. CarterJ.ManuscriptReview.IJG-D-16-00348.PredictivevalueoftheserumHE4andCA125concentrationsforthelymphaticmetastasisofendometrialcancer.6thApril2016
9. CarterJ.ManuscriptReview.“Cervicalcancerinwomenunder25yearsofageinQueensland,Australia:Isthenewnationalcervicalscreeningprogramsafeforyoungerwomen?”MJA16.00329.13thApril2016
10. CarterJ.ManuscriptReview.ManuscriptNumberANZJOG-2016-0335.Efficacyofintermittentpneumaticcompressionforvenousthromboembolismandprophylaxisinpatientsundergoinggynecologicsurgery:asystematicreviewandmetaanalysis.ANZJOG18thNovember2016
11. CarterJ.ManuscriptReview.ManuscriptNumberE16-1116.Theimpactofadjuvanthysterectomyonprognosisinpatientswithlocallyadvancedcervicalcancertreatedwithdefinitiveconcurrentchemoradiotherapy:Ameta-analysis.AmJObstetGynecol24thNovember2016
Pather1. PatherS.UnderstandingVulvarandVaginalCancers.CancerCouncilofNSW
21stSeptember2016.2. PatherS.IDCJOG-2016-0347Relationshipbetweenobesityand
symptomatologyinwomenundergoinghysterectomyforprolapse.JournalofObstetricsandGynaecology.2ndOctober2016
3. PatherS.ANZJOG-2016-0182entitled"Prognosticimpactofselectivelymphadenectomybasedonpre-operativecharacteristicsinpatientswithendometrialcancer:acase-controlstudy.August2016
4. PatherS.ANZJOG-2016-0326entitled"InitialobservationofCIN2doesnotappeartoreducequalityoflifeinwomenunder25yearsofage.December2016.
Saidi1. SaidiS.InternationalJournalofGynaecologicalCancer.IJGCIGC-D-16-00076.
22ndFebruary2016.2. SaidiS.Editor.CancerCouncil“UnderstandingCanceroftheUterus”official
patientpamphlet.20thDec2016.
Tejada-Berges1. Tejada-BergesT.NationalBreastCancerFoundation,Grantreviewer:2017
InfrastructureGrants.September2016.2. Tejada-BergesT.SupportiveCareinCancer,Manuscriptreview:Manuscript
No:JSCC-D-16-00642.September2016.3. Tejada-BergesT.IGCSJournal,manuscriptreview:ManuscriptIGC-D-16-
00557.November2016.
Philp1. PhilpS.Abstractreview:InternationalConferenceonCancerNursing(ICCN),
HongKong,China,September20162. PhilpS.AustralianJournalofCancerNursing,Manuscriptreview,ID2016-33. PhilpS.EuropeanJournalofCancerCare,Manuscriptreview,ECC-2015-
0190.R24. PhilpS.EuropeanJournalofCancerCare,Manuscriptreview,ECC-2015-
0190.R15. PhilpS.CancerCouncilNSW,UnderstandingOvarianCancerbooklet,June2016
18
Other1. WanKM.PeerreviewerforTrialsJournal,ProtocolTRLS-D-16-00265R121st
July20162. WanKM.PeerreviewerforTrialsJournal,ProtocolTRLS-D-16-00265R23rd
October2016
RANZCOGActivities
Pather1. PatherS.CollegeExaminerfortheCGOSubspecialityexaminations:College
HouseNovember2016
Saidi1. SaidiS.RANZCOGbasicsurgicalskillsworkshop.Trainer.20th-21stFeb20162. SaidiS.RANZCOGpart2revisioncoursepresentation.VulvalCancer.25thOct
20163. SaidiS.RANZCOGpart2revisioncoursepresentation.CervicalCancer.25thOct
2016
Tejada-Berges1. Tejada-BergesT.MRANZCOGRevisionCourse:SurgicalPelvicAnatomy,Rydges
Hotel,NorthSydney,24thOctober2016.2. Tejada-BergesT.MRANZCOGRevisionCourse:GestationalTrophoblastic
DiseaseReview,RydgesHotel,NorthSydney,25thOctober2016.3. Tejada-BergesT.MRANZCOGRevisionCourse:OvarianCancerManagement
Review,RydgesHotel,NorthSydney,25thOctober2016.
Other1. WanKM.AcceptedforGynaecologicalOncology(CGO)Trainingprogramfor
2017,SubspecialtiesTrainingProgram,RANZCOG2. WanKM.RANZCOGBasicSurgicalSkillsCourseFacilitator,KollingInstitute-
RoyalNorthShoreHospital,21stFebruary2016
EthicsSubmissions
Pather1. PatherS.Pelvicsepsisfollowingahysteroscopyforpyometria.Acasereport.2. HerbstU,WongE,PatherS.ProtocolNoX15-0389&HREC/15/RPAH/532-
“ImmunohistochemistryforHPVtestingonarchivedtissueinwomenwithbiopsyprovenhighgradecervicaldysplasiaandnegativeHPVtesting”
3. TongP,PatherS.ProtocolNoX16-0476&LNR/16/RPAH/680-“ThedemographicsandoutcomesofwomenwithStageIIendometrialcarcinomamanagedinAustralia(2005-2007)
19
GrantsSubmissions
Carter1. ObermairA,QuinnM,BrennanD,ArmesJ,JandaM(CI),CarterJ(AI).Improving
thetreatmentforwomenwithearlystagecanceroftheuterus(feMMe).2016NHMRCProjectGrant
MembershipsinProfessionalOrganizations
Carter1. CarterJ.RoyalAustralianCollegeObstetriciansandGynaecologists.2. CarterJ.AustralianMedicalAssociation.3. CarterJ.AustralianSocietyGynaecologicalOncologists.4. CarterJ.AmericanCollegeofSurgeons.5. CarterJ.InternationalSocietyofGynecologicCancer.6. CarterJ.SocietyofGynecologicOncologists.Member.7. CarterJ.UniversityofSydneyAssociationofProfessors.
EditorialCommittee
Pather1. PatherS.AustinJournalofObstetricsandGynaecology
CourseOrganizationorInstruction
Pather1. PatherS.ASCCPtreatmentcourseinGynaecologicDysplasia.Lifehouse19
November2016
Philp1. PhilpS.LecturerandCourseCoordinator,CancerandHaematologyNursing,
SydneyNursingSchool,TheUniversityofSydney2. PhilpS.OrganisingCommittee.ACIGONG,“CervicalCancer”,RPAH,3June20163. PhilpS.OrganisingCommittee.ACIGONG,“EndometrialCancer”,RPAH,28April
2017
Zielony1. ZielonyB.OrganisingCommittee.ACIGynaecologicalOncologyNurses&Allied
HealthGroup(GONG)“CervicalCancer”RPAH.3rdJune2016
Other1. TongP.FacilitatoratASCCPLEEPWorkshop.Sydney19thNovember20162. WanKM.ASCCPLEEPWorkshopFacilitator,ChrisO’BrienLifehouse
19thNovember2016
20
InvitedLectureship,Guest,ProgramChair,GrandRoundsPresentations
Philp1. PhilpS.Chairofsession.ACIGONG,“CervicalCancer”,RPAH,3June2016
Tejada-Berges1. Tejada-BergesT.InvitedLecturesforAcademiaMedical0b/GynReview
Course.23-25June,2016.
Other1. WanK,TejadaBergesT,“Overviewofendometrialhyperplasiaanduterine
cancer”2016FRANZCOGRevisionCourse.RydgesHotel,NorthSydney.25thOctober2016
2. WanK,“ApproachtoPVBleedingforInterns”RoyalPrinceAlfredHospital.9thNovember2016
Teaching,MedicalStudent&UniversityActivities
Carter1. CarterJ.Lecture.HPV,VaccinationandScreening.AbercrombieBusinessSchool
LectureTheatre,UniversityofSydney.24rdOctober2016
Pather1. PatherS.Co-organizer:CervicalCancerPathology,UniversityofSydney,21nd
October,2016.2. PatherS.Colposcopyandtreatmentofdysplasia.Scorpioyear2medicine.
ClinicalTrainingUnit,RPAH.21stOctober20163. PatherS.StudentLecturesMed4PostmenopausalbleedingandCervical
dysplasia/cancer15/03/16;17/05/16;19/07/16;04/10/16
Saidi1. SaidiS.UniversityofSydneyMedicalSchool.SCORPIOteachingsession.Smears
andcytology.21stOct20162. SaidiS.UniversityofSydneyMedicalSchool.Part2OSCEexaminer.1stNov
20163. SaidiS.UniversityofSydneyMedicalSchool.Stage2PPDinterviews.6th-14th
Nov2016.
Philp1. PhilpS.LecturerandCourseCoordinator,CancerandHaematologyNursing,
SydneyNursingSchool,TheUniversityofSydney2. PhilpS.ExpertPeerReviewPanelMember.MasterofNursing(NP)FinalViva,
October2016
TejadaBerges1. Tejada-BergesT.MedStudentLecture:EvaluationoftheAdnexalMass.17th
March2016.
21
2. Tejada-BergesT.MedStudentLecture:EvaluationoftheAdnexalMass.19thMay2016.
3. Tejada-BergesT.MedStudentLecture:EvaluationoftheAdnexalMass.21stJuly2016.
4. Tejada-BergesT.MedStudentLecture:EvaluationoftheAdnexalMass.6thOctober2016.
5. Tejada-BergesT.CervixCancerScorpioTutorial:MacroscopicFeaturesandClinicalStagingofCervixCancer.21stOctober2016.
Other1. RangelL,WanK,TongP,PatherS.Colposcopyandtreatmentofdysplasia.
MedicalstudentsScorpioteachingactivity.RoyalPrinceAlfredHospital,UniversityofSydney,Sydney,NSW,Australia,21October2016.
Courses&ConferencesAttended
Philp1. PhilpS.19thAnnualCNSAWinterCongress,Cairns,May20162. PhilpS.ACIGONG,“CervicalCancer”,RPAH,3June20163. PhilpS.NursingStrategyDayWorkshop,Lifehouse,July2016
TejadaBerges1. Tejada-BergesT.BRCA:ChallengesandOpportunities,SixthInternational
SymposiumonHereditaryBreastandOvarianCancer.CentreMont-Royal,Montréal,Canada.10-13May,2016.
Other1. TongP.AttendanceASGOASMConference.CradleMountainTasmania,19-21st
May20162. WanKM.AttendanceASGOASMConference.CradleMountainTasmania,19-
21stMay2016
22
Fundraising,Media
Carter1. CarterJ.Channel9News.TherenewaloftheNationalCervicalScreening
Program.17thOctober2016.http://www.mylifehouse.org.au/11189-2/
2. CarterJ.ABCRN.TherenewaloftheNationalCervicalScreeningProgram.17thOctober2016.http://www.abc.net.au/radionational/programs/healthreport/cervical-cancer-screening/7938108#transcript
Saidi1. SaidiS.Chairman’slunchpresentation.Supra-radicalsurgeryinOvarianCancer
–thecaseforaspecialisedcentre.ChrisO’BrienLifehouse.18thMarch2016
Tejada-Berges1. Tejada-BergesT.“BreakfastofChampions”.AustraliaSchoolFundraiserfor
ChrisO’BrienLifehouse.6thMay2016.
23
ResearchLHReference StudyTitle ProtocolLH13.003 PARAGON(ANZGOG0903)PhaseIIstudyof
aromataseinhibitorsinwomenwithpotentiallyhormoneresponsiverecurrent/metastaticgynaecologicalneoplasms
ANZGOG0903
LH13.036 APhaseIIIStudytoEvaluatetheEfficacyandSafetyofPazopanibMonotherapyVersusPlaceboinWomenWhoHaveNotProgressedafterFirstLineChemotherapyforEpithelialOvarian,FallopianTube,orPrimaryPeritonealCancer(OVAR16)
AGO-OVER16/VEG11065
5
LH13.039 ClinicalStudyNo.1199.15Multicenter,randomised,double-blindphaseIIItrialtoinvestigatetheefficacyandsafetyofBIBF1120incombinationwithcarboplatinandpaclitaxelcomparedtoplacebopluscarboplatinandpaclitaxelinpatientswithadvancedovariancancer(OVAR12)
AGO-OVER16/VEG11065
5
LH13.055 IBCSG24-02/BIG2-02:APhaseIIItrialevaluatingtheroleofovarianfunctionsuppressionandtheroleofexemestaneasadjuvanttherapiesforpremenopausalwomenwithendocrineresponsivebreastcancer(SOFT)
IBCSG24-02/BIG2-02
LH13.056 ANZGOG0902:APhaseIIItrialofadjuvantchemotherapyfollowingchemoradiationasprimarytreatmentforlocallyadvancedcervicalcancercomparedtochemoradiationalone(TheOUTBACKTrial)
ANZGOG0902
LH14.018 AninternationalphaseIIIrandomisedtrialofdose-fractionatedchemotherapycomparedtostandardthree-weeklychemotherapy,followingimmediateprimarysurgeryoraspartofdelayedprimarysurgery,forwomenwithnewlydiagnosedepithelialovarian,fallopiantubeorprimaryperitonealcancer-ICON8
Icon8
LH14.024 AGO-OVAR2.21/ENGOT-ov18:AProspectiverandomizedPhaseIIItrialofcarboplatin/gemcitabine/bevacizumabvs.carboplatin/pegylatedliposomaldoxorubicin/bevacizumabinpatientswithplatinum-sensitiverecurrentovariancancer(AnENGOT/GCIGTrial)(OVAR2.21)
AGO-OVAR2.21
24
LH14.029 EMR200066_012:PhaseIIRandomisedDoubleBlindPlaceboControlledTrialofCombinationofPimasertibwithSAR245409orofPimasertibwithSAR245409PlaceboinSubjectswithPreviouslyTreatedUnresectableLowGradeOvarianCancer
EMR200066_012
LH15.035 Impactofrisk-reducingbilateralsalpingo-oophorectomyonnon-canceroutcomesinyounghighriskwomen:Amulticentreprospectivestudy(WHAM)
WHAM
LH15.037 ClinicalauditofsinglesurgeonexperiencewithFastTrackSurgeryingynaecologicalpatients
Authorised
LH15.048 Theconservativemanagementofyoungwomen,uptoage25,withcervicalintraepithelialneoplasia(CIN)2(PRINCESS)
PRINCess
LH15.049 ANZGOG1301:APhaseIIRandomisedClinicalTrialofMirena±Metformin±WeightLossInterventioninPatientswithEarlyStageCanceroftheEndometrium(FEMME)
ANZGOG-1301
LH16.018 Genomicmechanismsunderlyinglong-termresponsetotreatmentinserousovariancancer:anAustralianOvarianCancerStudyProject(AOCS)
Authorised
LH16.022 ClinicalStudyNo.M13-694,APhase3Placebo-ControlledStudyofCarboplatin/PaclitaxelWithorWithoutConcurrentandContinuationMaintenanceVeliparib(PARPinhibitor)inParticipantswithPreviouslyUntreatedStagesIIIorIVHigh-GradeSerousEpithelialOvarian,FallopianTube,orPrimaryPeritonealCancer
M13-694
LH16.023 ImmunohistochemistyforHPVtestingonarchivedtissueinwomenwithbiopsyprovenhighgradecervicaldysplasiaandnegativeHPVtesting
LH16.025 UnderstandingEndofLifeDecisionMakinginCancer
LH16.027 IsPreoperativeCarbohydrateLoadingTolerableandBeneficialinGynaecologicOncologySurgery
CARBLOADING
LH16.028 TheRoleofAlpha-ParvininHumanEndometrialCancerCells
LH16.045 INOVATe-IndividualisedOvarianCancerTreatmentThroughIntegrationofGenomicPathologyintoMultidisciplinaryCare
LH16.047 AnauditofthedeliverabilityofCarboplatinandWeeklyPaclitaxelasAdjuvantTherapyforOvarianFallopiantubeandPrimaryPeritonealCancerPatients